New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 17, 2012
08:04 EDTIRWD, FRXIronwood, Forest announce U.S. availability of LINZESS
Ironwood Pharmaceuticals (IRWD) and Forest Laboratories (FRX) announced today that LINZESS is now available in pharmacies throughout the United States. The U.S. Food and Drug Administration recently approved LINZESS as a once-daily oral capsule for adult men and women suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation.
News For IRWD;FRX From The Last 14 Days
Check below for free stories on IRWD;FRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
May 17, 2013
10:36 EDTFRX, IRWDLeerink's major/specialty pharma analyst holds analyst/Industry conference call
Subscribe for More Information
May 15, 2013
11:37 EDTIRWDHigh option volume stocks: CONN IRWD JASO LYV CSC
May 10, 2013
10:00 EDTFRXOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: 3D Systems (DDD) initiated with a Buy at Janney Capital... Actavis (ACT) initiated with an Outperform at BMO Capital... Allergan (AGN) initiated with an Outperform at BMO Capital... Emeritus (ESC) initiated with an Outperform at Wells Fargo... Ensign Group (ENSG) initiated with a Market Perform at Wells Fargo... Forest Labs (FRX) initiated with an Underperform at BMO Capital... J2 Global (JCOM) initiated with an Outperform at Wedbush... Mylan (MYL) initiated with an Underperform at BMO Capital... Splunk (SPLK) initiated with a Market Perform at FBR Capital... Teva (TEVA) initiated with an Outperform at BMO Capital... Workday (WDAY) initiated with an Outperform at Oppenheimer... Nuance (NUAN) initiated with an Outperform at Wedbush... Demandware (DWRE) initiated with an Outperform at Wedbush... Synchronoss (SNCR) initiated with an Outperform at Wedbush... Trius Therapeutics (TSRX) initiated with a Buy at Guggenheim... Proto Labs (PRLB) initiated with a Buy at Janney Capital... Stratasys (SSYS) initiated with a Buy at Janney Capital.
May 9, 2013
16:34 EDTFRXForest Labs initiated with an Underperform at BMO Capital
Subscribe for More Information
06:05 EDTFRXForest Labs and Trevene to co-develop TRV027 for acute heart failure
Subscribe for More Information
May 7, 2013
07:24 EDTIRWDMizuho Securities to host a conference
Subscribe for More Information
May 6, 2013
10:04 EDTIRWDOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: C&J Energy (CJES) downgraded to Neutral from Buy at Goldman.... Corcept Therapeutics (CORT) downgraded to Neutral from Overweight at Piper Jaffray... Exelon (EXC) downgraded to Neutral from Buy at ISI Group... HeartWare (HTWR) downgraded to Neutral from Outperform at Credit Suisse... Kimco Realty (KIM) downgraded to Neutral from Buy at Goldman... Moody's (MCO) downgraded to Outperform from Strong Buy at Raymond James... PACCAR (PCAR) downgraded to Neutral from Buy at BofA/Merrill... Unum Group (UNM) downgraded to Hold from Buy at Deutsche Bank... Weatherford (WFT) downgraded to Neutral from Strong Buy at ISI Group... Churchill Downs (CHDN) downgraded to Neutral from Long-Term Buy at Hilliard Lyons... Electronic Arts (EA) downgraded to Sell from Hold at Hudson Square... Summit State Bank (SSBI) downgraded to Neutral from Long-Term Buy at Hilliard Lyons... Ironwood (IRWD) downgraded to Neutral from Outperform at Cowen... Oil States (OIS) downgraded to Neutral from Add at Capital One... CYS Investments (CYS) downgraded to Neutral from Buy at Nomura... American Capital Agency (AGNC) downgraded to Neutral from Buy at Nomura... Integrys Energy (TEG) downgraded to Neutral from Buy at DA Davidson... Oil States (OIS) downgraded to Accumulate from Buy at Tudor Pickering... Delcath Systems (DCTH) downgraded to Market Perform from Outperform at JMP Securities... Comerica (CMA) downgraded to Neutral from Buy at BTIG... Eldorado Gold (EGO) downgraded to Sector Perform from Outperform at RBC Capital
08:58 EDTIRWDIronwood downgraded to Neutral from Outperform at Cowen
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.